New imaging agent radiocaine enters human safety testing

NCT ID NCT07081217

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tests the safety and radiation of Radiocaine, a new radioactive tracer for PET scans. Six healthy adult volunteers will receive an injection and be monitored for side effects and radiation exposure. The goal is to see if Radiocaine can safely light up nerve activity in future imaging studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Radiocaine (a radioactive tracer for PET scans)

What this could lead to

If successful, this could lead to a new way to see nerve activity in the body using a PET scan.

What could go wrong

This is a very early, tiny trial (6 people) just checking safety and radiation. It may not lead to a useful diagnostic tool.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University School of Medicine

    RECRUITING

    Stanford, California, 94305, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••